Prohibits businesses in New York from selling medetomidine to individuals without proof of its intended use.
This bill amends the general business law to prohibit corporations, partnerships, limited liability companies, firms, online platforms, or any other business entities from knowingly selling, offering for sale, or delivering medetomidine to individuals without proof of its intended use for institutional, veterinary, or scientific purposes. It also prohibits sales to individuals under the age of twenty-one. Violations are subject to civil penalties, with funds deposited in the New York state drug treatment and public education fund.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.